Drug Shortage Report for ACUVAIL
Report ID | 97097 |
Drug Identification Number | 02369362 |
Brand name | ACUVAIL |
Common or Proper name | ketoroalac tromethamine |
Company Name | ALLERGAN INC |
Market Status | MARKETED |
Active Ingredient(s) | KETOROLAC TROMETHAMINE |
Strength(s) | 0.45% |
Dosage form(s) | SOLUTION |
Route of administration | OPHTHALMIC |
Packaging size | 60 x 0.4ml |
ATC code | S01BC |
ATC description | ANTIINFLAMMATORY AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-11-18 |
Estimated end date | 2019-12-13 |
Actual end date | 2019-11-07 |
Shortage status | Avoided shortage |
Updated date | 2019-11-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2019-11-07 | French | Compare |
v3 | 2019-11-07 | English | Compare |
v2 | 2019-10-24 | French | Compare |
v1 | 2019-10-24 | English | Compare |
Showing 1 to 4 of 4